@ebtapper

Hepatologist @michiganliver @vaannarbor; #cirrhosis; encephalopathy; frailty; quality improvement; father; husband. #livertwitter Co-EIC of @HepCommJournal

 Ann Arbor, MI
uofmhealth.org/profile/4313/elliot-benjamin-tapper-md
Joined September 2011
  • Tweets15.7K
  • Following657
  • Followers43.3K
2.9KMedia
I have been doing clinical trials to optimize the use of lactulose for >15 years With Eric Orman @IUGastro We have a new trial (POEM) launching for patients with recent HE I wish our treatment had no side effects but I am grateful to this magical syrup for what it can do
Elliot Tapper@ebtapper27 Sep 2018
Hepatic encephalopathy in the hospital (An ode to #lactulose): A brief #livertwitter #tweetorial Aims: 1. Share the greatest t-shirt ever made 2. Rule out infection! 3. Laxation now! But how? keywords: #cirrhosis, paracentesis, stool pH
6
1,421
What counts as evidence? Hepatologists have learned to thrive in data deserts. So how can we square the standards of Cochrane and GRADE with the data that we have? And should we? Ian and I in @FrontGastro_BMJ : fg.bmj.com/content/flgastro/…
1
9
17
1,521
Follow @JenLaiLiverDoc
Elliot Tapper@ebtapper23h
Everyone in hepatology and liver transplant is aware of Jennifer C. Lai, MD/MBA’s impact. This week we were privileged to have her as the Sheila Sherlock visiting professor at Michigan Hepatology
2
13
1,444
Everyone in hepatology and liver transplant is aware of Jennifer C. Lai, MD/MBA’s impact. This week we were privileged to have her as the Sheila Sherlock visiting professor at Michigan Hepatology
1
6
1
54
4,734
It is inspiring to see how someone builds a field, brick by brick, accomplishes so much and continues to innovate
1
4
775
Follow @JenLaiLiverDoc
1
589
Elliot Tapper retweeted
Jen Lai@JenLaiLiverDocOct 22
Fangirling over @umichmedicine Hepatology & LTx, home of the world’s best liver docs! Honored to be invited by the great Dr. Anna Lok for the Sheila Sherlock visiting professorship. #GoBlue (❤️ @zingermans) @ebtapper @NikMazumder_MD @pummy92 @RobertFontanaMD @HPB_Txp_Surg
2
3
19
1,544
📑 Seladelpar in patients with #PBC and compensated #cirrhosis: Efficacy and safety from RESPONSE and ASSURE studies‼️ #OpenAccess #LiverX journals.lww.com/hepcomm/ful…
15
1
41
1,963
📑#MetALD is emerging as a major 🌎 liver disease phenotype‼️ ⭐️10-20% of people with hepatic steatosis meet MetALD criteria❕ ⚠️Metabolic dysfunction ➕ alcohol 🍻➡️ increased risks of fibrosis progression, cirrhosis, & HCC❕ #OpenAccess journals.lww.com/hepcomm/ful…
31
71
3,509
🏆 Your #HepMadness2026 bracket could win you AASLD swag! Prizes include an AASLD swag bag with an AASLD water bottle, liver socks, and much more! ⏰ Submit your bracket by October 31 for a chance to win! 👇 tourneytopia.com/aasld/hepma…
5
1
7
1,318
📑 L-Taurine for #Fatigue in Decompensated Cirrhosis⁉️ ❎ Negative trial overall ⭐️ BUT, patients without anemia🩸 had a large ⬇️ in fatigue 😴, while those with anemia did not❕ #OpenAccess #LiverX journals.lww.com/hepcomm/ful…
1
10
20
1,259
📑 Low serum pseudocholinesterase levels are associated with mortality in patients with #HCC‼️ #OpenAccess #LiverX journals.lww.com/hepcomm/ful…
2
7
9
1,076
You should always err on the side of COI disclosure @sanapirzadaMD is a role model Check it out👇👇👇👇
Sana Pirzada, MD@sanapirzadaMDOct 17
Call me biased, but “Disease Overlap” is the clear contender. No conflicts of interest here 🤷🏻‍♀️ 👀 @LiverFellow @AASLDtweets #Hepmadness2026
6
1,976
The use of “defined daily doses” or DDD to measure “dose effect” is a big problem and should be avoided when attempting to make claims regarding the effect on or association with an outcome. It may just be measuring event-free survival!
1
1
4
1,613
Huge review on patient and caregiver reported outcome in ascites from Dr Sumita Verma’s group journals.lww.com/hepcomm/ful… Open access in @HepCommJournal Everything from pooled estimates to impact of interventions

Patient-reported and caregiver-reported outcomes... : Hepatology Communications

Background: Refractory ascites (RA) secondary to advanced chronic liver disease (ACLD) results in poor health-related quality of life (HRQL), high...

journals.lww.com
8
16
1,717
What happens to gut bacteria on rifaximin? Big changes and rifampin resistance
16
58
4,301
📑 Group-based #telehealth 💻behavioral interventions for chronic liver disease‼️ A 14-week group telehealth intervention achieved 84% retention & 91% session attendance❕ ⭐️Improvement trends in stress, coping, relaxation 🧘, & sleep hygiene 😴 journals.lww.com/hepcomm/ful…
1
6
10
1,048
Elliot Tapper retweeted
Vinay Jahagirdar
@vinayjahaOct 17
Have you signed up for #HepMadness2026 yet? 🏆 16 hepatology themes go head-to-head! A great learning opportunity with recent articles handpicked from @LTxJournal & @HepCommJournal, summarized by team @LiverFellow. Open to ALL! Make your picks by Oct 31! 🔥 Sign up & FAQs here 🔗 aasld.org/liver-fellow-n… 🥇 to be announced at #TLM2026 @AASLDtweets @AASLDFoundation @AASLDPresident @ebtapper @jlouissaint89 @WAleyadeh @SarahKhan9894
Liver Fellow Network@LiverFellowOct 16
Replying to @LiverFellow
5/6 Here’s the full bracket. 👇 Tell us your champion pick right now. Bold calls only. Upsets encouraged.
6
1
13
1,344
Elliot Tapper retweeted
Wesam Aleyadeh@WAleyadehOct 16
Head over to tourneytopia.com/aasld/hepma…. Submit your picks! @LiverFellow @AASLDtweets
Liver Fellow Network@LiverFellowOct 16
1/6 🚨 THE BRACKET IS LIVE 🚨 HepMadness 2026 starts NOW. 16 themes. 4 rounds. 1 champion 🏆 The best hepatology and transplant science of the year, going head to head. Who survives? #HepMadness2026 aasld.org/liver-fellow-netwo…
4
2
636
HepMadness!!!! Pick the most important topic in hepatology The tournament is back. Fill out your brackets here tourneytopia.com/aasld/hepma…
2
11
20
3,927
Load more